Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-064512
Filing Date
2013-12-26
Accepted
2013-12-26 08:27:47
Documents
1
Period of Report
2013-12-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rrd398102.html 4  
1 PRIMARY DOCUMENT rrd398102.xml 4 3278
  Complete submission text file 0001181431-13-064512.txt   4958
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Issuer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 23622 CALABASAS ROAD, SUITE 300 CALABASAS CA 91302
Business Address
Gringeri Anthony (Reporting) CIK: 0001584851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35560 | Film No.: 131297893